Earnings Recaps

Browse reported earnings of the most popular stocks

Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025 Dec 2, 2025 Dec 1, 2025 Nov 27, 2025 Nov 26, 2025 Nov 25, 2025 Nov 24, 2025 Nov 23, 2025 Nov 21, 2025 Nov 20, 2025 Nov 19, 2025 Nov 18, 2025 Nov 17, 2025 Nov 15, 2025 Nov 14, 2025 Nov 13, 2025 Nov 12, 2025 Nov 11, 2025 Nov 10, 2025 Nov 9, 2025 Nov 8, 2025 Nov 7, 2025 Nov 6, 2025 Nov 5, 2025 Nov 4, 2025 Nov 1, 2025 Oct 31, 2025 Oct 30, 2025 Oct 29, 2025 Oct 28, 2025 Oct 27, 2025 Oct 25, 2025 Oct 24, 2025 Oct 23, 2025 Oct 22, 2025 Oct 21, 2025 Oct 17, 2025 Oct 16, 2025 Oct 15, 2025 Oct 14, 2025 Oct 9, 2025 Oct 8, 2025 Oct 7, 2025 Sep 25, 2025 Sep 23, 2025 Sep 17, 2025 Sep 16, 2025 Sep 11, 2025 Sep 10, 2025 Sep 9, 2025 Sep 5, 2025 Sep 4, 2025 Sep 3, 2025 Sep 2, 2025 Sep 1, 2025 Aug 28, 2025 Aug 26, 2025 Aug 25, 2025 Aug 22, 2025 Aug 21, 2025 Aug 20, 2025 Aug 19, 2025 Aug 18, 2025 Aug 15, 2025 Aug 14, 2025 Aug 13, 2025 Aug 12, 2025 Aug 11, 2025 Aug 9, 2025 Aug 8, 2025 Aug 2, 2025 Aug 1, 2025 Jul 30, 2025 Jul 29, 2025 Jul 25, 2025
8 companies Today

Chewy, Inc.

CHWY Q3 2025
Reported: 2025-12-10

Chewy's Q3 2025 results demonstrate strong growth and profitability, with net sales surpassing expectations and margin expansion reflecting robust operational execution.

Key takeaways
  • Q3 net sales increased 8.3% year-over-year to $3.12 billion, driven by strong Autoship growth and customer acquisition.
  • Adjusted EBITDA rose 30% to $181 million, with adjusted EBITDA margin expanding to 5.8% due to improved gross margins and disciplined SG&A management.
  • Free cash flow generated in the quarter totaled $176 million, facilitating $55 million in share repurchases and strategic investments.
  • Continued strong performance from Chewy Vet Care and the expansion of Chewy+ membership program signal a positive outlook for customer loyalty and recurring revenue.
  • Chewy aims for long-term adjusted EBITDA margin of 10%, supported by structural efficiencies and a growing premium health product assortment through recent acquisitions.

Chemring Group PLC

CMGMY Q4 2025
Reported: 2025-12-10

Chemring’s FY 2025 results reflect solid performance amidst U.K. government spending challenges, with a record order book supporting a strategic path to double revenues by 2030.

Key takeaways
  • Group revenue rose 2% to GBP 498 million, with operating margin improving from 14.3% to 14.8%.
  • Record order intake of GBP 781 million, up 20% year-on-year, contributing to a total order book of GBP 1.3 billion, a 32% increase.
  • Strong cash conversion at 114% and EPS growth of 3% against a backdrop of higher tax and finance costs.
  • Significant growth in the Countermeasures & Energetics segment, with operating profit up 37% and margins reaching 19.1%.
  • Continued investment in operational excellence underscores Chemring’s commitment to sustainable, long-term value creation amidst rising global defense spending.

Compass Minerals International, Inc.

CMP Q4 2025
Reported: 2025-12-10

Compass Minerals reported significant improvement in key financial metrics for FY 2025, achieving a notable reduction in net losses and a strong focus on operational restructuring, positioning the company for sustainable growth.

Key takeaways
  • Consolidated revenue reached approximately $1.25 billion, an 11% year-over-year increase.
  • Adjusted EBITDA surged almost 107% to $35 million, while quarterly adjusted EBITDA rose to $42 million, up from $16 million year-over-year.
  • Successfully reduced net debt by 14% ($125 million) and improved financial flexibility through a midyear refinancing initiative.
  • Strategic reduction in corporate costs led to an 18% decrease in SG&A expenses, contributing to a $25 million year-over-year improvement.
  • Sales volumes in the Plant Nutrition segment grew by 19%, reflecting the effectiveness of operational enhancements.

Community

See what investors are trading, holding, and sharing

🌐
All
📈
Stock
📊
ETF
🏦
Mutual Fund
🪙
Crypto
💱
Forex
# Asset Price Community % Type Currency Sector
Loading...